M&A Deal Summary

Berry Consultants Acquires ICON - ADDPLAN Software

On March 1, 2022, Berry Consultants acquired software company ICON - ADDPLAN Software from ICON

Acquisition Highlights
  • This is Berry Consultants’ 1st transaction in the Software sector.
  • This is Berry Consultants’ 1st transaction in Ireland.

M&A Deal Summary

Date 2022-03-01
Target ICON - ADDPLAN Software
Sector Software
Buyer(s) Berry Consultants
Sellers(s) ICON
Deal Type Divestiture

Target

ICON - ADDPLAN Software

Dublin, Ireland
ICON's ADDPLAN Software is a stand-alone software used to design, simulate, and analyze innovative adaptive clinical trials with functionality for all phases of clinical development.

Search 205,528 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Berry Consultants

Austin, Texas, United States

Category Company
Founded 2000
Sector Software
DESCRIPTION

Berry Consultants is a statistical consulting company specializing in innovative clinical trial design, analysis, execution, and software solutions for the pharmaceutical and medical device industry. Berry Consultants was founded in 2000 and is based in Austin, Texas.


DEAL STATS #
Overall 1 of 1
Sector (Software) 1 of 1
Type (Divestiture) 1 of 1
Country (Ireland) 1 of 1
Year (2022) 1 of 1

Seller(S) 1

SELLER

ICON

Dublin, Ireland

Category Company
Founded 1990
Sector Life Science
Employees41,100
Revenue 8.1B USD (2023)
DESCRIPTION

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. ICON was founded in 1990 and is based in Dublin, Ireland.


DEAL STATS #
Overall 1 of 1
Sector (Software) 1 of 1
Type (Divestiture) 1 of 1
Country (Ireland) 1 of 1
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-24 PRA Health Sciences

Raleigh, North Carolina, United States

PRA Health Sciences, Inc. is an international clinical research organization. PRA provides services on a contract basis to the pharmaceutical and biotechnology industries. Comprehensive services include the filing of Investigational New Drug (IND) and similar regulatory applications, management and implementation of Phase I through IV clinical trials, preparation and submission of New Drug Applications (NDAs), and post-marketing surveillance on an international basis. PRA was formed in 1976 and is based in Raleigh, North Carolina.

Buy $12.0B